| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 145.16M | 153.07M | 147.40M | 140.19M | 124.33M | 109.02M |
| Gross Profit | 40.26M | 44.49M | 44.82M | 39.08M | 42.22M | 31.88M |
| EBITDA | 20.84M | 24.22M | 19.31M | 19.05M | 21.52M | 15.70M |
| Net Income | 11.26M | 14.40M | 10.94M | 13.31M | 15.15M | 9.77M |
Balance Sheet | ||||||
| Total Assets | 172.36M | 169.85M | 175.02M | 188.18M | 149.42M | 123.52M |
| Cash, Cash Equivalents and Short-Term Investments | 2.57M | 1.79M | 809.00K | 2.35M | 7.26M | 7.74M |
| Total Debt | 1.62M | 2.52M | 11.19M | 24.77M | 16.37M | 7.31M |
| Total Liabilities | 29.22M | 27.84M | 37.77M | 54.33M | 43.12M | 32.40M |
| Stockholders Equity | 143.14M | 142.01M | 137.25M | 133.85M | 106.30M | 91.12M |
Cash Flow | ||||||
| Free Cash Flow | 17.57M | 15.40M | 15.78M | -14.16M | -5.80M | -11.33M |
| Operating Cash Flow | 23.12M | 21.07M | 21.49M | -1.39M | 8.57M | 13.49M |
| Investing Cash Flow | -5.79M | -5.63M | -4.16M | -7.17M | -14.36M | -24.88M |
| Financing Cash Flow | -16.62M | -14.37M | -12.51M | 4.38M | 963.00K | -3.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | £128.52M | 11.82 | 8.02% | 4.08% | 1.12% | -0.70% | |
65 Neutral | £3.85B | 27.52 | 6.17% | 3.45% | 2.36% | -13.99% | |
64 Neutral | £948.96M | -17.58 | 3.37% | 1.34% | -11.78% | -92.61% | |
63 Neutral | £274.44M | 29.72 | 3.48% | 2.44% | -4.71% | 86.21% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | £15.51M | -16.08 | -12.88% | ― | 25.56% | 35.12% | |
51 Neutral | £103.04M | -1.24 | -7.26% | ― | -4.41% | 2.29% |
Treatt PLC has announced interim management appointments following the upcoming departure of CEO David Shannon. Manprit Randhawa, currently Interim CFO, will assume the role of Interim Group Managing Director, while Kelly Gordon will take on expanded responsibilities within the finance function. These changes are aimed at ensuring business continuity and effective leadership until a new CEO is appointed. The company will release its full-year results for FY25 on January 20, 2026, and hold its AGM on March 26, 2026.
The most recent analyst rating on (GB:TET) stock is a Hold with a £252.00 price target. To see the full list of analyst forecasts on Treatt plc stock, see the GB:TET Stock Forecast page.
Treatt PLC has announced the upcoming departure of Philip O’Connor from his role as a Non-executive Director, effective 28 February 2026, after four years on the Board, including three as Senior Independent Director. The company is actively searching for new Non-executive Directors, and O’Connor will continue to assist in finalizing the Annual Report and Accounts for the year ending 30 September 2025. This change in the board’s composition may influence Treatt’s strategic direction and governance as it continues to serve the beverage, flavour, and fragrance industries.
The most recent analyst rating on (GB:TET) stock is a Hold with a £252.00 price target. To see the full list of analyst forecasts on Treatt plc stock, see the GB:TET Stock Forecast page.
Treatt PLC has announced that David Shannon will step down as Chief Executive and Director on December 31, 2025. The Board has started a formal search for a new Chief Executive to lead the company into its next phase, emphasizing the importance of long-term leadership. This transition is expected to be smooth, with the current leadership team facilitating the handover process.
The most recent analyst rating on (GB:TET) stock is a Hold with a £252.00 price target. To see the full list of analyst forecasts on Treatt plc stock, see the GB:TET Stock Forecast page.
Treatt PLC announced that Bronagh Kennedy will step down as a Non-executive Director at the end of her three-year term on January 31, 2026, to focus on other board roles. The company is in the process of appointing a new Non-executive Director, highlighting its commitment to maintaining strong leadership and governance. This change may impact the company’s board dynamics and strategic direction, with potential implications for stakeholders as Treatt continues to strengthen its position in the natural extracts and ingredients market.
The most recent analyst rating on (GB:TET) stock is a Hold with a £252.00 price target. To see the full list of analyst forecasts on Treatt plc stock, see the GB:TET Stock Forecast page.
Treatt PLC announced the lapse of a proposed acquisition by Natara Global Limited due to insufficient shareholder approval at recent meetings. Despite the setback, Treatt remains committed to its strategic goals and continues to engage with major stakeholders like Döhler Group SE, which has shown support for Treatt’s market position and strategy.
The most recent analyst rating on (GB:TET) stock is a Buy with a £285.00 price target. To see the full list of analyst forecasts on Treatt plc stock, see the GB:TET Stock Forecast page.